10x Genomics, Inc. (TXG) News
Follow 10x Genomics, Inc. (TXG) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 35 public stories across 21 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Analysts Revise 10x Genomics Price Targets After Q3 Earnings
Deutsche Bank cut its target to $50 from $70 and kept a Hold rating; UBS cut its target to $61 from $90 and maintained Neutral. Stifel raised its target to $68 from $50 and maintained Buy.
EQUITY | Nov 06, 2026, 07:03 PM UTC
M
10x Genomics Reports Quarterly Results Through September 30
A machine-generated LSEG earnings summary covers the quarter ended September 30; the supplied body provides no financial results.
EQUITY | Nov 06, 2026, 12:49 AM UTC
M
10x Genomics Reports Q3 Revenue of $150.7 Million, Raises 2026 Guidance
Third-quarter revenue was $150.7 million versus a $148.0 million FactSet consensus estimate. The company reported a $0.15-per-share loss, narrowed operating losses to $16.1 million from $32.2 million a year earlier, and
EQUITY | Nov 05, 2026, 11:02 PM UTC
M
10x Genomics Reports Third-Quarter Loss of $19.4 Million
EQUITY | Nov 05, 2026, 09:07 PM UTC
M
10x Genomics Raises 2026 Revenue Guidance to $625M–$635M
Q3 2026 revenue was $150.7 million, compared with $149.0 million a year earlier. The company expects 4%–6% revenue growth over 2025 excluding non-recurring patent-litigation settlement revenue in both years.
EARNINGS | Nov 05, 2026, 09:06 PM UTC
M
10x Genomics Reports Third-Quarter 2026 Financial Results
10x Genomics reported results for the quarter ended September 30, 2026.
EQUITY | Nov 05, 2026, 09:06 PM UTC
M
10x Genomics to Report Third-Quarter 2026 Results November 5
10x Genomics said it will report its third-quarter 2026 financial results on November 5, 2026.
EQUITY | Oct 13, 2026, 08:05 PM UTC
H
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Friday. Shares of Humana Inc (NYSE: HUM ) rose sharply after the company said Friday that its 2027 Medicare Advantage Star Ratings improved
LIVE | Oct 09, 2026, 02:51 PM UTC
M
Torex Gold Reports Q3 2026 Production
Torex Gold Resources Inc. reported its third-quarter 2026 production results, stating that the performance firmly positions the company to achieve its full-year production guidance.
EQUITY | Oct 06, 2026, 10:01 AM UTC
H
10 Stocks Rally as Rate Hike Bets Collapse on Weak September Jobs
A weak jobs report usually worries Wall Street, but on Friday, it sent stocks higher. The U.S. economy added just 29,000 jobs in September, far below the 90,000 economists had expected, the Bureau o f Labor Statistics sa
LIVE | Oct 02, 2026, 01:46 PM UTC
L
10x Genomics Price Target Raised to $90.00/Share From $40.00 by Leerink Partners
Ratings actions from Benzinga
NEWS | Sep 29, 2026, 04:38 PM UTC
L
10x Genomics (TXG) Launches Sentira Spatial GPU Analysis Platform
10x Genomics launched Sentira, starting with Sentira Spatial Analysis, a cloud platform using NVIDIA accelerated computing to cut core spatial data processing from hours to minutes. Early Access is free for Xenium or Ate
NEWS | Sep 29, 2026, 01:02 PM UTC
L
10x Genomics (TXG) Begins Global Shipments of Atera
10x Genomics, Inc. started worldwide shipments of its Atera spatial biology platform, with booked 2026 orders previously disclosed as exceeding the 40 instruments the company expected to ship this year.Material DetailsCo
NEWS | Sep 29, 2026, 01:01 PM UTC
L
10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions
Sentira Spatial Analysis leverages NVIDIA accelerated computing to cut spatial data processing times from hours to minutes, putting rapid, iterative analysis at the fingertips of every researcherPLEASANTON, Calif., Sept.
NEWS | Sep 29, 2026, 01:01 PM UTC
L
10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands
Extraordinary early global demand, ambitious new research programs and an expansive technology roadmap mark the beginning of a new era for biological understandingPLEASANTON, Calif., Sept. 29, 2026 // -- 10x Genomics, In
NEWS | Sep 29, 2026, 01:01 PM UTC
L
10x Genomics (TXG) Stock Is Up, What You Need To Know
What Happened? Shares of biotech company 10x Genomics NASDAQ:TXGjumped 2.8% in the afternoon session after Argus analyst John Eade initiated coverage on the company with a Buy rating.The new coverage established Argus's
EQUITY | Sep 28, 2026, 08:15 PM UTC
L
10x Genomics Is Maintained at Neutral by Piper Sandler
Ratings actions from Benzinga
NEWS | Sep 28, 2026, 04:09 PM UTC
L
Torex Gold Resources Inc. Price Target Raised to C$89.00/Share From C$71.00 by ATB Cormark
Ratings actions from Baystreet: GMT) Torex Gold Resources Inc. Raised to Outperform From Sector Perform by ATB CormarkRatings actions from Baystreet
COMMODITIES | Sep 28, 2026, 03:31 PM UTC
L
10x Genomics Price Target Announced at $110.00/Share by Argus Research
Ratings actions from Benzinga: GMT) 10x Genomics Initiated at Buy by Argus ResearchRatings actions from Benzinga
NEWS | Sep 28, 2026, 12:20 PM UTC
L
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid Services moved to cancel Affordable Care Act coverage for roughl
REGULATION | Sep 23, 2026, 08:42 PM UTC
H
Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Dow Jones index falling around 300 points on Tuesday. Shares of Radiant Logistics Inc (NYSE: RLGT ) rose sharply after the company reported better-than-expected fourth-quarter financial r
LIVE | Sep 15, 2026, 01:53 PM UTC
L
Cathie Wood Makes Striking Switch Between AI Stock Giants
Cathie Wood's Ark Invest made a sharp rotation across technology and biotechnology stocks last week, buying roughly $28 million of Meta Platforms NASDAQ:META while selling a nearly identical dollar amount of Alphabet NAS
EQUITY | Sep 15, 2026, 12:21 PM UTC
L
UBS maintains neutral rating on 10x Genomics
UBS maintained a neutral rating on 10x Genomics, according to Benzinga ratings actions.
EQUITY | Sep 09, 2026, 06:08 PM UTC
L
10x Genomics director sells Class A stock for $1,235,071
Director John R Stuelpnagel reported Class A common stock sales on 2026-09-03, totaling $1,235,071 for 20,000 shares at weighted average prices of $60.6579, $62.1082 and $62.6066.
EQUITY | Sep 08, 2026, 11:10 PM UTC
L
RBC Capital sets $70 price target for 10x Genomics
Benzinga reports RBC Capital initiated coverage on 10x Genomics at Sector Perform and set a $70.00/share price target.
EQUITY | Sep 01, 2026, 12:11 PM UTC
L
IMR appoints independent director and names CFO
IMR appoints Paul Larkin as an independent director and Robert Scott as CFO.
EQUITY | Aug 31, 2026, 04:06 AM UTC
L
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
EQUITY | Aug 28, 2026, 09:23 PM UTC
M
10x Genomics jury finds Qiagen unit Parse Biosciences infringed
U.S. jury found a Qiagen unit infringed patents held by Parse Biosciences, per TradingView News.
EQUITY | Aug 28, 2026, 06:40 PM UTC
M
10x Genomics wins patent verdict against Parse Biosciences
10x Genomics won a patent infringement verdict against Parse Biosciences.
EQUITY | Aug 28, 2026, 06:39 PM UTC
L
Insiders sold TXG shares worth over $3.1M
Insiders at TXG sold shares worth over $3.1M, per TradingView News.
EQUITY | Aug 26, 2026, 08:52 PM UTC
L
10x Genomics Raises FY2026 Sales Guidance from $600.000M-$625.000M to $610.000M-$630.000M vs $613.851M Est
10x Genomics (NASDAQ: TXG ) raises FY2026 sales outlook from $600.000 million-$625.000 million to $610.000 million-$630.000 million vs $613.851 million estimate.
EARNINGS | Aug 06, 2026, 08:07 PM UTC
M
TXG Collaborates with Lausanne University Hospital
TXG partners with hospital for cancer research
EQUITY | Jul 29, 2026, 01:00 PM UTC
H
10x Genomics price target raised to $37 from $22 at Morgan Stanley
Morgan Stanley analyst Kallum Titchmarsh raised the firm's price target on 10x Genomics to $37 from $22 and keeps an Equal Weight rating on the shares. The firm is updating its model ahead of the earnings report.
EQUITY | Jul 09, 2026, 10:56 AM UTC
L
Piper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $42
Piper Sandler analyst David Westenberg maintains 10x Genomics (NASDAQ: TXG ) with a Neutral and raises the price target from $20 to $42.
EQUITY | Jul 01, 2026, 01:25 PM UTC
M
TXG: Barclays Raises Target
10x Genomics shares are trading higher after Barclays raised its price target on the stock from $30 to $40.
EQUITY | Jun 24, 2026, 07:47 PM UTC